cinogen 3 :4-benzpyrene ' (6) and they discovered ( 3 , 7 ) that methylcholanthrene (8) surpasses even this substance in the rapidity of tumor induction. Both 3 :4-benzpyrene and methylcholanthrene contain the 1 :2-benzanthracene ring system, and it seemed significant that the latter hydrocarbon carries substituents in the 5 and 6 positions. As one phase of the work undertaken at Harvard on the basis of these important advances, an attempt was made to define further the features of structure responsible for the pronounced activity of these two hydrocarbons, and it is with this problem that the present report is concerned.
In tests conducted by one of us (9) with methylcholanthrene produced by synthesis (10) or from cholic acid ( 1 1 ) , with 3:4-benzpyrene prepared by an improved process ( 12) , and with the more common 1 : 2 : 5 : 6-dibenzanthracene, the order of potency for the three hydrocarbons indicated by the results obtained in London was fully confirmed. Using the technic of injecting the crystalline material subcutaneously in 5-to 10-mg. dosage into pure-strain mice, and testing the malignant nature of the tumor tissue in representative cases by transplantation, he observed significant differences in the rapidity of action of the hydrocarbons, although they all eventually produced tumors in a large proportion of the animals tested.
It is not known why certain hydrocarbons act rapidly, while with others there is a prolonged latent period before any changes are detected, but it seems proper to consider both the rapidity and the regularity of tumor induction in defining the general carcinogenic potency of a given compound. A few hydrocarbons are appropriately classified as '' weakly carcinogenic " because they give rise only to occasional tumors, but with the majority of compounds having carcinogenic properties the principal variable factor is the time element, and it is convenient to adopt as the basis for discussion some CARCINOGENIC ACTIVITY OF 1 : 2-BENZANTHRACENE DERIVATIVES 261 means of summarizing the data pertaining to the rapidity of action of compounds which act with about the same high degree of regularity. As a roughly quantitative estimate of the rapidity of action of such compounds, we may define tentatively the " average time " of the appearance of tumors in mice in the experiments of Shear (9) as the time required for tumor production in approximately half of the animals tested. This time varies with the technic of administration and with the species and strain of animals used, and results more accurate than those at present available undoubtedly can be obtained by controlling these conditions still more carefully and by employing large numbers of animals.
The approximate average time of the appearance of malignant tumors in the recorded experiments is as follows: methylcholanthrene, 2.5 months; 3 :4-benzpyrene, 3.5 months; 1 : 2 : 5 : 6-dibenzanthracene, 7 months. While subject to the limitations noted, these provisional figures afford a convenient indication of the relative carcinogenic potency of the three hydrocarbons. In the accompanying chart compounds producing tumors in an average time of less than 4 months are characterized as "rapid " in their action, those with which this time is 4 to 6 months are called " moderately rapid," those for which the time is 6 to 9 months are called " slow," and compounds which give rise to a large proportion of tumors but which do so, on the average, after the ninth month are classified as " very slow."
It was of particular interest to attempt to discover the factors contributing to the high potency of methylcholanthrene (Formula I ) as compared with other 5 : 6-disubstituted 1 : 2-benzanthracenes such as the 5 :6-benz-derivative (Formula I I ) , and the development of a flexible and general method of synthesis (10, 13) made it possible to investigate certain variations in the structure. At the beginning a study was made of the effect of further elaborations of the methylcholanthrene molecule. A hydrocarbon prepared ( 14) by the general synthesis and represented by Formula 111, 16 : 20-dimethylcholanthrene (sterol numbering system), has an additional methyl group located in the five-membered ring. The introduction of this group was found (9) to result in a distinct decrease in activity, the (' average time " being about 7.5 months.
1':9-Methylene-l: 2 : 5 : 6-dibenzanthracene (15), Formula IV, has the cholanthrene ring system, it carries a carbon substituent at the position occupied by the methyl group of methylchoIanthrene, and it combines as well the structural features of the slowly acting 1 : 2 : 5 : 6-dibenzanthracene. While the substance has definite cancer-producing properties, the latent period ( 11 months) is considerably longer than for either of the hydrocarbons to which it is structurally related. The fusing of an additional benzenoid nucleus to the five-membered ring of the cholanthrene structure, giving 15 : 16-benzdehydrocholanthrene ( 16), Formula V, practically destroys the carcinogenic activity. Although other variations in the same direction are being investigated, it seems evident from the results now available that an increase in the complexity of the structure results in a loss in cancer-producing activity.
As a step in the opposite direction, the parent hydrocarbon cholanthrene, Formula VI, was synthesized both in London (17) and at Harvard (16) , and it was found (9, 2) to be only slightly less potent ( 3 mos.) than methylcholanthrene, showing that the methyl group of the latter is of no great importance.
This observation suggested to us the idea that it might be profitable to investigate further simplifications of the molecule, even though there were certain indications in the results of Cook, Kennaway, and co-workers that cholanthrene represents the limiting structure likely to be associated with a high order of activity. If cholanthrene has no special character other than that it is a dimethylene derivative of 1 : 2-benzanthracene, one would expect it to be comparable with dialkyl derivatives of this hydrocarbon, but the English workers had studied a large number of such compounds without encountering any that approached cholanthrene in potency (2, 3, 4 ) . No appreciable carcinogenic properties were noted for the 3-, 4-, 7-, 2'-, or 3'-methyl derivatives of 1 : 2-benzanthracene, the 3'-, 7-, or 10-isopropyl compounds, the 10-benzyl derivative, the 9: 10-diphenyl compound, or for 2':6-, 2': 7-, 3': 6-, or 3': 7-dimethyl-1 : 2-benzanthracene. On the other hand, various 5-and 6-substituted 1 : 2-benzanthracenes were found to possess carcinogenic activity. The 5-n-propyl and 6-methyl derivatives of 1 : 2-benzanthracene were observed to have weakly developed cancer-producing properties, slowly giving tumors in about one-third of the mice tested. A greater regularity of action was observed in the case of 5-methyl-and 6-isopropyl-l:2-benzanthracene, as well as with the 5:6-and 6:7-dimethyl compounds, and with the 5 : 6-and 6 : 7-trimethylene (cyclopenteno) compounds, for these six hydrocarbons gave rise to tumors in as many as 70 to 80 per cent of the animals tested. On the basis of these results the view was expressed ( 3 ) " that attachment of .alkyl groups to positions 5 or 6 (or both) of the 1 :2-benzanthracene molecule gives molecular conditions which are f avourable for cancer-producing activity." With the reservation that the effect of a simple alkyl substituent at position 8 would be worthy of attention, the English investigators concluded that substituents are more efficacious at positions 5 and 6 than at other parts of the molecule ( 3 , 4 ) .
However regular in their action, the above 1 : 2-benzanthracene derivatives alkylated in the 5-, 5 : 6-, and 6 : 7-positions produce tumors only slowly. When applied to the skin of mice in benzene solution, they give tumors in about half of the animals in periods varying from approximately 7.5 months to 11.5 months ( 3 ) . The hydrocarbons are roughly comparable with the slowly acting 1 : 2 : 5 : 6-dibenzanthracene, but they do not approach cholanthrene and methylcholanthrene in potency. On application to the skin in benzene solution, cholanthrene gave 11 tumors in 50 mice after 110 days (4), while methylcholanthrene produced tumors in about half of a group of animals in slightly more than 3 months ( 3 ) . The rapidity of the carcinogenic action of the cholanthrenes seemed to place these hydrocarbons in a class apart from all of the alkylated 1 :2-benzanthracenes which had been investigated and, in view of this striking contrast, Cook, Kennaway, and co-workers were led to conclude (5) that " The essential structural feature is the pentacyclic system present in the molecule."
While it appeared entirely plausible on the basis of the available evidence that the striking potency of cholanthrene and methylcholanthrene is associated with the presence of a five-membered ring in combination with the 1 : 2-benzanthracene system, it seemed to us desirable to test this important point still more rigidly. Cholanthrene is the 5 : 10- thracene and, although the English workers had determined the influence of a methyl group at position 5, the information from their data regarding the effect of substitution at the 10-position is limited to results with hydrocarbons having rather elaborate groups (isopropyl, benzyl, phenyl) at this position, It was thought that the effect of a 10-methyl group was worthy of investigation, and that a comparison of cholanthrene with 5 : 10-dimethyl-1 :2-benzanthracene (Formula VII) would provide an entirely sound basis for judging whether the pronounced carcinogenic activity of the former hydrocarbon is due to the presence of the alicyclic ring including carbon atoms 5 and 10, or merely to the presence of simple alkyl substituents at these positions. With this end in view, a method was developed for the synthesis of 10-methyl-and 5: 10-dimethyl-1 :2-benzanthracene (18) , and the known 5-methyl compound was prepared for comparison by the new synthesis. While the animal experiments have not been in progress for a sufficient length of time to warrant final conclusions regarding the exact relationship of each compound to other members of the series, the results now available are of considerable interest. Crystalline 5 : 10-dimethyl-1 : 2-benzanthracene, injected into 16 mice in 10-mg. dosage, produced 2 tumors in 2.5 months. Three more tumors were obtained in the next 2 weeks, and at the end of 4 months a total of 8 tumors had been obtained. The other mice died during this period for reasons apparently associated with the severe ulceration produced by the hydrocarbon at the injection site. Two of the tumors were successfully transplanted and are now in their third generation. Crystalline 5-methyl-1 : 2-benzanthracene, injected in 5-mg. dosage into 20 mice, produced no ulceration and the first tumors were obtained after 3.5 months. At the end of 4 months only 3 tumors had appeared. Crystalline 10-methyl-1 : 2-benzanthracene, injected in 5-mg. dosage into 20 mice, produced severe ulceration at the site of injection after a month, and at the end of 2 months small tumors were noted in 8 mice. After 4 months, tumors had been obtained in 15 of the 20 mice. Three of these tumors were successfully transplanted.
It is quite evident from these results that 5 : 10-dimethyl-1 :2-benzanthracene and 10-methyl-1 : 2-benzanthracene are comparable with methylcholanthrene and cholanthrene in the rapidity and regularity of tumor production. They surpass by far the other alkyl and dialkyl 1:2-benzanthracenes and rank with the most potent known carcinogenic agents. The preliminary results with the 5-methyl compound confirm the observation of the English investigators ( 3 ) that the compound is much slower in its action than the cholanthrenes.
The observation that 5 : 10-dimethyl-1 :2-benzanthracene (VII) is of the same order of carcinogenic activity as cholanthrene ( V I ) , from which it differs only in having two additional atoms of hydrogen in place of the linkage connecting the methylene groups, shows that the five-membered ring characteristic of the cholanthrene system is of importance in contributing to the activity of hydrocarbons of this type only in that it includes simple substituents at positions 5 and 10, and that the intact ring is by no means essential. Of the two methyl or methylene groups, clearly that at the 10-position is the more important. It is remarkable in the light of the earlier observations that a substance of the simple structure of 10-methyl-1 : 2-benzanthracene should possess cancer-producing activity comparable with that of methylcholanthrene. When the previous results are viewed in retrospect, substitution at positions 5 and 6 appears to be of secondary importance. While it is true that 5 :6-dialkyl-1 : 2-benzanthracenes regularly exhibit carcinogenic properties, and while this fact provided a valuable clue which led to the discovery of carcinogenic activity among the cholanthrenes, it appears at present that the most important structural feature of methylcholanthrene is not the 5 : 6-disubstitution, or the presence of an added ring, but substitution at the meso-position 10. It is interesting that 3:4-benzpyrene (Formula X ) may be regarded as a 1 : 2-benzanthracene derivative with a carbon substituent at the alternate meso-position 9. Furthermore, the isomer of cholanthrene represented in Formula XI, 8 : 9-dimethylene-l : 2-benzanthracene ( 16), is definitely carcinogenic (9), although the action of the compound is rather slow (" average time," 7 months). Possibly the presence of a substituent at the 9-position is a factor of significance in the case of both compounds, and this hypothesis is under investigation. One of us (M. S. N.), in work which is being conducted independently but in understanding with the group, has synthesized 9-methyl-1 :2-benzanthracene (m.p. 138.4-138.8", corr.) and 5 :9-dimethyl-1 :2-benzanthracene (m.p. 135-135.5", corr.) and tests for cancer-producing properties are in progress.
That too great an elaboration of an effective type of structure may result in loss of potency has been demonstrated repeatedly, and a further example is that 7-methyl-8 :9-dimethylene-l : 2-benzanthracene (lo), shown in Formula XII, is inactive (9) . Particularly striking is the case of the 10-isopropyl compound (Formula XIII), which was prepared by Cook (19) in 1932 and  found ( 2 , 3 ) to be inactive. The contrasting effect of the methyl and isopropyl groups at the 10-position seems surprising in the light of the observation (3) that 6-methyl-1 :2-benzanthracene gave tumors in only one-third of the animals tested while the 64sopropyl compound gave tumors in about two-thirds of the mice to which it was administered. This situation is reversed, however, in the case of the 5-methyl and 5-n-propyl compounds, for here the hydrocarbon with the larger alkyl group gave only about one-third as many tumors as the lower homologue (4) and the relationship, at least with respect to the size of the groups, seems to be similar to that for substituents at position 10. It is perhaps well to regard these comparisons as purely provisional, however, for they are based only upon the total number of tumors obtained in tests with small numbers of mice. The relationship between the 10-methyl and 10-isopropyl compounds may be compared also with that between the potent methylcholanthrene and the slowly acting 16 : 20-dimethylcholanthrene (Formula 111). The latter hydrocarbon differs from the former in having a larger and more highly branched substituent at the 10-position. It obviously is important to explore the gap between the highly potent 10-methyl compound and the inactive 10-isopropyl derivative and to search for compounds of intermediate activity. If a series of closely related hydrocarbons of graduated carcinogenic activity were available it might be profitable to attempt to correlate the biological activities of the compounds with their physical and chemical properties. The preparation of a series of homologous 10-alkyl-l : 2-benzanthracenes, and of other 10-substituted derivatives, is in progress (L. F. F. and E. B. H.) and the 10-ethyl compound, m.p. 113.5-114", corr., has been injected into test animals.4 4: 10-Dimethylene-1 : 2-benzanthracene, an isomer of cholanthrene, also has been synthesized (20) , and preliminary tests (9) indicate that the compound produces interesting biological changes. An attempt was made to synthesize 5 : 10-trimethylene-1 : 2-benzanthracene for comparison with cholanthrene, but the only product obtained was a hydrocarbon regarded as having the structure of an isomer, 1 : 12-trimethylenechrysene (2 1).
Having found that the molecule of methylcholanthrene can be stripped of certain of its appendages without loss of the characteristic potency, it seemed important to determine if 10-methyl-1 : 2-benzanthracene represents the limit to which simplification can be carried. The 10-methyl group, of course, cannot be removed without almost complete loss of carcinogenic properties ( 3 ) , but it seemed worth while to determine if the angular ring of the l:2-benzanthracene system is capable of modification without disappearance of activity. The fact that the 5 : 6-cyclopenteno-and 5 : 6-dimethyl derivatives of 1 : 2-benzanthracene have about the same carcinogenic activity as 1 : 2 : 5 : 6-dibenzanthracene ( 3 ) shows that one of the angular rings of the latter hydrocarbon can be replaced by a cyclopenteno ring or by two methyl groups, respectively, with retention of the original potency, and it is conceivable that the one remaining angular ring of 1 :2-benzanthracene can be modified in the same way with similar results. In order to test this point, the hydrocarbons represented in Formulas XIV and XV were synthesized (22) for comparison with cholanthrene (Formula VI), and tests are now in progress.
One phase of our work has been concerned with the obviously interesting problem of preparing derivatives of carcinogenic hydrocarbons having substituents other than alkyl groups. The influence of such substituents on the carcinogenic properties of the compounds would be interesting in itself, and with carcinogenically active substances available having suitable functional groups it would be possible to attach side chains of such a nature as to vary the solubility relations in different directions. Such developments would broaden greatly the 'field of biological experimentation. The addition product of 1 : 2 : 5 : 6-dibenzanthracene and maleic anhydride ( 3 ) and the molecular compounds of carcinogenic hydrocarbons with desoxycholic acid (23) are of interest in this connection because they form water-soluble alkali salts capable of giving rise to tumors, but, since it is possible that they may act only by virtue of a dissociation to the components in the body, these compounds perhaps belong in a somewhat different category from the substituted aromatic compounds envisioned. The line of work indicated has not been stressed heretofore in our laboratories because it seemed essential at the outset to define as clearly as possible the limits of carcinogenic potency among the hydrocarbons and to develop satisfactory general methods for the synthesis of compounds of the effective types of structure. The road is now clear for the elaboration of this part of the problem and several lines of investigation A satisfactory method for the synthesis of 10-alkyl derivatives has been found in the action of Grignard reagents on pure, anthranol-free 1 : 2-benz-10-anthrone, followed by thermal dehydration of the reaction products.
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As far as we are aware, 4'-hydroxy-3 :4-benzpyrene (24) , shown in Formula XVI, is the first pure hydroxylated derivative of an actively carcinogenic hydrocarbon thus far synthesized and tested. After 16 months, the crystalline substance has produced no tumors at the site of injection. The action of the methyl ether of the compound is such as to suggest that it may prove to be weakly carcinogenic. It is interesting that 9-methoxy-l : 2 : 5 : 6-dibenzanthracene has been found by Cook and co-workers (3) to have carcinogenic properties. 3-Methoxy-l : 2-benzanthracene, shown in Formula XVII, was synthesized some years ago by one of us with Dietz (25), and as a test with an original sample gave interesting results, the experiment was repeated with fresh material. Although the action of the substance is slow, tumors were obtained at the site of injection in several of the animals, as will be described later in a detailed report. Tests with 3-hydroxy-l : 2-benzanthracene (25) were negative until very recently, when 2 of 10~mice that had received injections of the crystalline hydroxy compound were found after 8 months to have tumors at the site of injection. These mice were males and the tumors were in immediate contact with injected material still present. It is too early to draw any conclusions from these preliminary results, but obviously the hydroxyl and methoxyl derivatives of carcinogenic hydrocarbons offer a promising field for further investigation. The preparation of one series of compounds which combine features of the structures illustrated in Formulas IX and XVII has been completed (L. F. F. and E. B. H.) ; 3-methoxy-l0-methyl-1:2-benzanthracene (m.p. 183-183.5", corr.) and the 10-ethyl and 10-n-propyl compounds are in the process of being tested.
One other compound with functional substituents which has been investigated is 3 :4-benzpyrene-3' :4'-dicarboxylic anhydride (26). Injected subcutaneously into mice, the anhydride produced interesting changes in the liver which will be described later. The corresponding disodium and dipotassium salts appeared to injure the vascular system.
CONCLUSIONS
While the important problem of determining the manner in which certain hydrocarbons of the 1 : 2-benzanthracene series initiate malignant growth remains unsolved, the clear definition of the structural features which are essential for the development of high carcinogenic potency may clarify the problem and point the way to an eventual solution. The recognition that cancer-producing power of a high order is associated with simple meso-alkyl 1 : 2-benzanthracenes opens various new lines of investigation, as does the discovery of carcinogenic properties in 3-hydroxy-l : 2-benzanthracene and its methyl ether.
The discovery of substances far simpler in structure than methylcholanthrene which approach this compound in carcinogenic potency has a possible bearing on the hypothesis ( 7 ) that cancer-producing hydrocarbons may arise in the organism by the abnormal metabolism of cholesterol or of bile acids. Hitherto this hypothesis has found some support not only in the demonstration that bile acids can be transformed by chemical means into methylcholanthrene (8, l l ) , but also in the apparently striking circumstance that this particular hydrocarbon, which carries as a mark of its possible origin the five-membered ring characteristic of the sterols and sex hormones, is outstandingly potent in comparison with all previously known compounds except cholanthrene. Since the investigation of the possible biological formation of methylcholanthrene by direct experimentation presents unusual difficulties, the circumstantial lines of evidence have been of considerable importance in molding current views. The present results indicate, however, that the high potency of methylcholanthrene is due chiefly to the fact that the hydrocarbon is a derivative of 1 :2-benzanthracene having an alkyl substituent in the 10-position, and that similarly constituted hydrocarbons of far simpler structure share its remarkable carcinogenic activity. 10-Methyl-and 5 : 10-dimethyl-1 : 2-benzanthracene lack both the cyclopentano ring and the C,,-methyl group characteristic of the sterols and bile acids, and there is at present no good reason for supposing that these hydrocarbons can arise in the body. It is still entirely possible that methylcholanthrene is involved in the incidence of some forms of spontaneous cancer, but we feel that our results weaken somewhat the purely circumstantial evidence pointing in this direction.
